首页> 美国卫生研究院文献>other >Radiofrequency Ablation of the Main Lesion of Hepatocellular Carcinoma and Bile Duct Tumor Thrombus as a Radical Therapeutic Alternative
【2h】

Radiofrequency Ablation of the Main Lesion of Hepatocellular Carcinoma and Bile Duct Tumor Thrombus as a Radical Therapeutic Alternative

机译:射频消融肝癌和胆管肿瘤血栓的主要病变作为一种根治性治疗方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatocellular carcinoma (HCC) with bile duct tumor thrombus (BDTT) formation is a rare entity found microscopically in 1% to 9.2% of resected specimens. The ideal treatment for HCC is surgical resection. However, because of poor hepatic functional reserve in patients with HCC, most tumors are unresectable. Here, we report 2 cases of HCC with BDTT type III accompanied by hepatic dysfunction that were successfully treated with radiofrequency (RF) ablation. We used RF ablation as both a radical therapeutic method and an efficient way to control bleeding from the origin of BDTT after BDTT removal. At the time of writing, the 2 patients have been disease-free for 16 and 12 months, respectively.Our results show that RF ablation may be used as a radical therapeutic alternative for HCC with BDTT in patients with liver cirrhosis and obstructive jaundice.
机译:胆管肿瘤血栓(BDTT)形成的肝细胞癌(HCC)是在显微镜下发现的1%至9.2%的标本中很少见的实体。肝癌的理想治疗方法是手术切除。然而,由于肝癌患者肝功能储备差,大多数肿瘤无法切除。在这里,我们报告2例BDTT III型伴有肝功能不全的HCC,已成功通过射频消融治疗。我们将射频消融既作为一种基本的治疗方法,又作为一种有效的方法来控制从BDTT去除后的BDTT起源出血。在撰写本文时,这两名患者分别无病生存16个月和12个月。我们的结果表明,射频消融可作为肝硬化和梗阻性黄疸患者用BDTT替代HCC的根本疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号